Metabolic Peptide

GLP-2 (TR)

TirzepatideGIP/GLP-1 Dual AgonistCAS: 2023788-19-2

A 39-residue synthetic linear peptide that acts as a dual agonist at both the GIP and GLP-1 receptors. A C20 fatty diacid chain at Lys-20 drives albumin binding for a once-weekly circulation profile. Premium Direct-Supply Peptide

MassChoose an option

Quantity

From$116

Contact to Purchase

Fast, protected deliveryTracked USA shipping with discreet packaging.

Tracked USA delivery

Free shipment protection

Priority shipping available

Verified Test Results

Every batch, independently verified.

Each batch is analyzed by an ISO/IEC 17025 accredited third-party laboratory. The report below reflects the identity, purity and full-panel specification data reported by the lab.

ILSILS LaboratoriesCertificate of Analysis≥99%Purity by HPLC

ISO 17025 Accredited8× Tested

ParameterResultMethodSpecification

Peptide Purity (HPLC)99.76%HPLC>= 95%

Net Peptide Content31.5mgHPLCReport

Identity (HPLC)ConfirmedHPLCMeets spec

AppearanceGoodVisualMeets spec

Fentanyl ScreenNot DetectedImmunoassayPass

Heavy Metals (ICP-MS)Not DetectedICP-MSPass

Sterility (PCR)No GrowthPCRPass

Endotoxin (USP <85>)< 0.05 EU/mLUSP <85>Reported

Third-Party Verified

Certificate of Analysis

Every lot is HPLC-tested at an ISO/IEC 17025-accredited lab. Open any batch's certificate below.

COA information

GLP-2 (Tirzepatide) 30mg

Latest

LOT TRZ0001

99.76%HPLC purity · meets spec

Labeled: 30mg
Measured: 31.5mg
Identity: Confirmed
Heavy metals: Not Detected
Sterility: No Growth
Endotoxin: < 0.05 EU/mL
Tested: Aug 3, 2026

8 assays passed · ISO/IEC 17025 accredited

Compound Information

Technical specifications

MOLECULAR PROFILE

What Is Tirzepatide?

A 39-residue synthetic linear peptide that acts as a dual agonist at both the GIP and GLP-1 receptors. A C20 fatty diacid chain at Lys-20 drives albumin binding for a once-weekly circulation profile.

Dual-Incretin AnalogAlbumin-Bound